NO20024821L - Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar - Google Patents

Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar

Info

Publication number
NO20024821L
NO20024821L NO20024821A NO20024821A NO20024821L NO 20024821 L NO20024821 L NO 20024821L NO 20024821 A NO20024821 A NO 20024821A NO 20024821 A NO20024821 A NO 20024821A NO 20024821 L NO20024821 L NO 20024821L
Authority
NO
Norway
Prior art keywords
blood vessels
diseases caused
medicines
stenotic lesions
hydrogen
Prior art date
Application number
NO20024821A
Other languages
English (en)
Other versions
NO20024821D0 (no
Inventor
Hiroyuki Matsuno
Toshihiko Uematsu
Original Assignee
Ono Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ono Pharmaceutical Co filed Critical Ono Pharmaceutical Co
Publication of NO20024821D0 publication Critical patent/NO20024821D0/no
Publication of NO20024821L publication Critical patent/NO20024821L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/166—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the carbon of a carboxamide group directly attached to the aromatic ring, e.g. procainamide, procarbazine, metoclopramide, labetalol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Forebyggende og/eller terapeutiske midler for sykdommer som skyldes stenotiske lesjoner i blodkar, som inneholder som den aktive bestanddel hydroksaminsyrederivater med den generelle formel (I) som utviser matriksmetalloprotease-inhiberende aktivitet eller ikke-toksiske salter derav: hvori Rer hydrogen, C-alkyl eller C-x alkyl substituert med ORidet Rer hydrogen, Calkyl, benzyl eller Q-s alkyl substituert med Q-k alkoksy.
NO20024821A 2000-04-06 2002-10-04 Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar NO20024821L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2000104344 2000-04-06
PCT/JP2001/002946 WO2001076587A1 (fr) 2000-04-06 2001-04-05 Remedes aux maladies associees aux lesions stenosees de vaisseaux sanguins

Publications (2)

Publication Number Publication Date
NO20024821D0 NO20024821D0 (no) 2002-10-04
NO20024821L true NO20024821L (no) 2002-12-06

Family

ID=18617901

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20024821A NO20024821L (no) 2000-04-06 2002-10-04 Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar

Country Status (15)

Country Link
US (1) US20040068015A1 (no)
EP (1) EP1275385A1 (no)
JP (1) JPWO2001076587A1 (no)
KR (1) KR20020087124A (no)
CN (1) CN1434709A (no)
AU (1) AU4683601A (no)
BR (1) BR0109889A (no)
CA (1) CA2404775A1 (no)
HU (1) HUP0300368A3 (no)
MX (1) MXPA02009839A (no)
NO (1) NO20024821L (no)
RU (1) RU2002126568A (no)
TW (1) TW575421B (no)
WO (1) WO2001076587A1 (no)
ZA (1) ZA200207974B (no)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2435072A2 (en) * 2009-05-27 2012-04-04 Yeda Research and Development Co. Ltd. Proteasome inhibitors and uses thereof
KR20200116096A (ko) * 2018-02-01 2020-10-08 웰스태트 테러퓨틱스 코포레이션 우리딘의 전신 전달을 위한 조성물 및 장치

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5843089A (en) * 1990-12-28 1998-12-01 Boston Scientific Corporation Stent lining
US5516781A (en) * 1992-01-09 1996-05-14 American Home Products Corporation Method of treating restenosis with rapamycin
ES2284180T3 (es) * 1996-01-23 2007-11-01 SHIONOGI & CO., LTD. Derivados de aminoacidos sulfonados e inhibidores de metaloproteinasas que contienen los mismos.
US6420427B1 (en) * 1997-10-09 2002-07-16 Ono Pharmaceutical Co., Ltd. Aminobutyric acid derivatives

Also Published As

Publication number Publication date
HUP0300368A3 (en) 2004-07-28
KR20020087124A (ko) 2002-11-21
RU2002126568A (ru) 2004-03-20
JPWO2001076587A1 (ja) 2004-01-08
EP1275385A1 (en) 2003-01-15
TW575421B (en) 2004-02-11
BR0109889A (pt) 2003-06-03
AU4683601A (en) 2001-10-23
WO2001076587A1 (fr) 2001-10-18
MXPA02009839A (es) 2003-09-22
CA2404775A1 (en) 2002-10-02
CN1434709A (zh) 2003-08-06
ZA200207974B (en) 2004-02-10
HUP0300368A2 (hu) 2003-07-28
US20040068015A1 (en) 2004-04-08
NO20024821D0 (no) 2002-10-04

Similar Documents

Publication Publication Date Title
TW200614983A (en) 5-substituted-2-phenylamino benzamides as MEK inhibitors
NO950297D0 (no) Prolinamidderivater
LU90956I2 (fr) Metvix principe actif méthylaminolevulinique sous forme d'un selde préférence l'hyhrochlorure méthylaminolevulinique
NO20045137L (no) Diketohydrazinderivatforbindelser og legemidler inneholdende forbindelser som aktiv ingrediens
CA2223403A1 (en) Substituted (sulfinic acid, sulfonic acid, sulfonylamino or sulfinylamino) n-¬(aminoiminomethyl)phenylalkyl|-azaheterocyclylamide compounds
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
IT1305306B1 (it) Uso della pirenoxina per la protezione dei tessuti corneali ininterventi di fotocheratectomia.
HUP0201284A2 (hu) Hatóanyagként kinazolindionszármazék kimáz inhibitort tartalmazó gyógyászati készítmények fibrózis megelőzésére vagy kezelésére
BG104797A (en) Use of dexmedetomi dine for sedative effect in patients in an intensive care unit
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
DE60220055D1 (de) 4-(4-methoxybenzyl)-n'-(5-nitro-1,3-thiazol-2-yl)harnstoff und dessen verwendung bei der behandlung von mit glycogensynthasekinase-3 (gsk3) assoziierten leiden
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
NO20024821L (no) Legemidler for sykdommer som skyldes stenotiske lesjoner i blodkar
RU2001118854A (ru) Оптически активное производное пиридил-4н-1,2,4-оксадиазина и его применение при лечении сосудистых заболеваний
SE0201837D0 (sv) Chemical compounds
SE9900190D0 (sv) New compounds
ES2123808T3 (es) Derivado de acilfenilglicina y agente profilactico y curativo para enfermedades causadas por una actividad acrecentada de colagenasa, que contiene dicho compuesto como ingrediente activo.
NO20043286L (no) Piperidinderivatforbindelser og legemidler inneholdende forbindelsene som den aktive bestanddel
ATE352317T1 (de) Therapeutische behandlung von eosinophilie durch verwendung von chymase-inhibitoren als aktiven bestandteilen
ATE408413T1 (de) Pralmorelin-haltige nasentropfen-präparate
EP0950409A4 (en) INHIBITORS OF SUBEPITHELIAL TURBIDITY
DE60233578D1 (de) Phosphorenthaltende Verbindugnen mit antithrombitische Wirkung
WO2003018564A1 (fr) Inhibiteur d'acat selectif de la paroi vasculaire
DE60106246D1 (de) Malto-oligosaccharide und deren verwendung
EP1228761A3 (en) Liquid pharmaceutical composition for treating bone diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application